Skip to content
LaunchIndex
Browse/2026/10/tomerbronshtein.com

Tomer Bronshtein, PhD | Biopharma Executive

tomerbronshtein.com

LaunchIndex first observed Tomer Bronshtein, PhD | Biopharma Executive (tomerbronshtein.com) live on 8 October 2026. View its launch screenshot, category, and verification evidence.

Screenshot of tomerbronshtein.com
Captured October 08, 2026 06:17 as part of the recorded launch evidence.
Observed launch story

A launch record built from evidence.

Tomer Bronshtein, PhD | Biopharma Executive (tomerbronshtein.com) was first observed live on 8 October 2026.

Biopharma executive offering translational strategy, development planning, partnerships, valuation, and financing services for healthcare technologies.

Its profile is classified as Portfolio within Services / Professional services.

Recorded evidence

What the launch signal contained.

First observed live
Previous state
No prior non-live observation
Last verified
Canonical host
tomerbronshtein.com
Category
Services / Professional services
Website type
Portfolio
Observed title
Tomer Bronshtein, PhD | Biopharma Executive
Observed description
Biopharma executive bridging scientific and clinical evidence with development strategy, partnerships, valuation and financing.
Detected technologies
None detected
Screenshot captured
Evidence source
Browser observation · Local
Evidence confidence
93%
HTTP status
200
Website owner

Is this your website?

Claim this profile to add verified owner information.

Claim website
Community signal

What do you make of this launch?

Vote on the site and leave a short note for other people exploring the new web.

↑0Up
↓0Down

Join the discussion

Sign in with Google to vote or comment.

Sign in to participate

Comments

0 comments
No comments yet

Be the first to leave a useful observation.

Report an issueFlag spam, illegal or harmful content, or inaccurate information.

Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.

Private to moderators · 10–2,000 characters